Cargando…
Survival in People Living with HIV with or without Recurrence of Hepatocellular Carcinoma after Invasive Therapy
SIMPLE SUMMARY: Few data are available on HCC outcomes in people living with HIV (PLWH), especially regarding HCC treatment and recurrence. We focused our study on survival and recurCitation: Bertoni, C.; Galli, L.; Lolatto, R.; Hasson, H.; Siribelli, A.; Messina, E.; Castagna, A.; Uberti-Foppa, C.;...
Autores principales: | Bertoni, Costanza, Galli, Laura, Lolatto, Riccardo, Hasson, Hamid, Siribelli, Alessia, Messina, Emanuela, Castagna, Antonella, Uberti Foppa, Caterina, Morsica, Giulia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046370/ https://www.ncbi.nlm.nih.gov/pubmed/36980538 http://dx.doi.org/10.3390/cancers15061653 |
Ejemplares similares
-
Levels of Alpha-Fetoprotein and Association with Mortality in Hepatocellular Carcinoma of HIV-1-Infected Patients
por: Morsica, Giulia, et al.
Publicado: (2022) -
Geographic Distribution of HCV-GT3 Subtypes and Naturally Occurring Resistance Associated Substitutions
por: Bagaglio, Sabrina, et al.
Publicado: (2019) -
Risk of HIV viral rebound in HIV infected patients on direct acting antivirals (DAAs) treatment for HCV
por: Morsica, Giulia, et al.
Publicado: (2022) -
Compartmentalization of Resistance-Associated Substitutions in HIV/HCV-Infected Patients: Possible Correlation with Infecting HCV Genotype
por: Morsica, Giulia, et al.
Publicado: (2021) -
A Prospective Italian Study on Baseline NS3 and NS5A Resistance to Direct-Acting Antivirals in a Real-World Setting of HIV-1/HCV Coinfected Patients and Association with Treatment Outcome
por: Bagaglio, Sabrina, et al.
Publicado: (2020)